# OnCo record nct05399654 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05399654/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05399654", "NCT05399654" ;
  schema:name "A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors"@en ;
  schema:description "A phase 1/2 trial of TAC-001 run by Tallac Therapeutics, of unknown status on the registry."@en ;
  schema:url <https://onco.cc/trials/nct05399654/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05399654> ;
  onco:status "historic" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:drugs <https://onco.cc/drugs/tac-001/> ;
  onco:companies <https://onco.cc/companies/tallac-therapeutics/> .